Quick navigation menu :
  1. Go to content
  2. Go to the main sections menu
  3. Go to the subsections menu
  4. Go to the search engine
  5. Go to the languages menu
  6. Go to the help menu
  7. Go to the slots
  8. Go to contact slot
You are here:
  1. Home
  2. > Press room
  3. > Events
  4. > Year 2007
Languages menu :
 

Contacts

Press Relations
Tel. :
(33) 1 53 77 4450
Fax :
(33) 1 53 77 4622
Adress :
174, avenue de France
75013 PARIS
FRANCE
Switchboard :
(33) 1 53 77 4000
Content :

Events 2007

En savoir plus sur le Chiffre d’affaires et Résultats du 3ème trimestre 2007

November 29, 2007 Collaboration with Regeneron

Collaboration agreement with Regeneron to develop and commercialize fully-human therapeutic antibodies was reviewed at 12 noon (CET) by Mr. Jean-Claude Muller, Senior Vice President Administration and Resources, and Mr. Jean-Michel Lévy, Senior Vice President Business Development. The presentation was followed by a Q&A session.

 
To find out more on Third Quarter 2007 Sales and Earnings

October 31, 2007 Third Quarter 2007 Sales and Earnings

The Third Quarter 2007 Sales and Earnings were reviewed at 8 a.m (CET) by Mr. Hanspeter Spek, Executive Vice President, Pharmaceutical Operations and Mr. Jean-Claude Leroy, Executive Vice President, Finance and Legal. The presentation was followed by a Q&A session.

 
To find out more on the Research and Development Meeting

September 17, 2007 Research and Development Meeting

This meeting, intended for Analysts and Investors, started at 2 p.m. (CET) and included presentations on the Research Portfolio of our main therapeutic areas. There were two Q&A sessions.

 
To find out more on First Half 2007 Sales and Earnings

August 1, 2007 First Half 2007 Sales and Earnings

The First Half 2007 Sales and Earnings were reviewed at 8 a.m (CET) by Mr. Hanspeter Spek, Executive Vice President, Pharmaceutical Operations and Mr. Jean-Claude Leroy, Executive Vice President, Finance and Legal. The presentation was followed by a Q&A session.

 
Listen to the conference on Rimonabant

June 29, 2007 Rimonabant Regulatory Update

The Rimonabant Regulatory Update was reviewed in English at 6 p.m (CET) by Mr. Marc Cluzel, Senior Vice President Scientific and Medical Affairs and Mr. Jean-Pierre Lehner, Senior Vice President, Medical and Regulatory Affairs. The teleconference was followed by a Q&A session.

 
Read more about the General Meeting 2007

May 31, 2007 General Meeting 2007

The General Meeting of sanofi-aventis shareholders took place on May 31, 2007 in Paris.

 
To find out more on First Quarter 2007 Sales and Earnings

May 3, 2007 First Quarter 2007 Sales and Earnings

The First Quarter 2007 Sales and Earnings were reviewed at 8 a.m (CET) by Mr. Hanspeter Spek, Executive Vice President, Pharmaceutical Operations and Mr. Jean-Claude Leroy, Executive Vice President, Finance and Legal. The presentation was followed by a Q&A session.

 
To find out more on Paris Information Meeting

February 13, 2007 Paris Information Meeting - 2006 Full-Year Results
Commercial Operations and Research & Development Review

The introduction was made at 8:30 a.m (Paris time) by Mr. Jean-François Dehecq (President). Mr. Gérard Le Fur (Chief Executive Officer) opened the meeting. 2006 Full-Year results were reviewed successively by Mr. Hanspeter Spek (Executive Vice President Pharmaceutical Operations), Mr. Wayne Pisano (Senior Vice President Commercial Operations & Corporate Strategy, sanofi pasteur) and Mr. Jean-Claude Leroy (Executive Vice President CFO). Mr. Marc Cluzel (Senior Vice President Science and Medical Affairs) and Mr. Pierre Chancel (Senior Vice President Global Marketing) presented the Commercial Operations and Research & Development. The presentation was followed by a Q/A session.

 
© sanofi-aventis 2004-2008 | Legal notice | Update: March 4, 2008